Indefinite Delivery Contract 75N93025D00013
Award Date 9/15/25
Last Date to Order 9/14/32
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Southern Research Institute, a non-profit research organization based in Birmingham, Alabama, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID) with a ceiling value of $255.8 million. The contract was awarded on September 15, 2003, with an ultimate completion date of December 11, 2015. The contract supports research and development in the physical, engineering, and life sciences, with all work performed at Southern...
- This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The contract has a ceiling value of $136,588,701.00 and a period of performance from September 30, 2025 to September 29, 2035. The purpose of this contract is to provide "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Southern Research Institute, a non-profit research organization, to provide preclinical development support for candidate products and drug development activities related to HIV therapeutics. The contract does not have a set-aside designation and has a period of...
- This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. federal government. The contract has a single awardee, Sri International, a non-profit research and development institute headquartered in Menlo Park, California. The contract has a ceiling value of $50,000,000 and a period of performance ending on September 14, 2032. The purpose of this contract is to provide INTERVENTIONAL AGENTS SAFETY AND...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
- The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit organization. The contract, valued at up to $24,293,824, is for an "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" and does not have a set-aside designation. Under this IDC, Southern Research Institute is providing a range of services, including optimization and...
- The National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, with a potential value of $545,452,906 and period of performance from September 1, 2021 through August 31, 2028. The contract provides comprehensive and rapid response services to support NIAID's research programs including clinical trials, manufacturing, nonclinical studies, analytics, and basic research. A $2,000 firm fixed...